Clinical Trial NCT06934967

Trial

Novartis – CLNP023I12201 (NCT06934967)

Clinical trial ID

NCT06934967

Drug name

LNP023

Company:

Novartis Pharmaceuticals

Drug trade name

iptacopan

Clinicaltrials.gov

Learn more

Phase of study

3

Current status

Active, not recruiting

Start

07/2025

Substance

Research question

To assess whether iptacopan is safe and well tolerated when used for the treatment of pediatric paroxysmal nocturnal hemoglobinuria (PNH)

Delivery method of drug

Frequency

Clinical trial locations